Defining your claims under MDR:
Turning safety claims into clinical endpoints on CE-mark studies

Question: How do you go about turning safety claims into clinical endpoints on CE-mark studies?

MD-Clinicals’ Danielle Giroud and Renata Nogueira explore the aspects of quantifying safety claims in this insightful discussion bringing the specifics behind defining your safety claims under MDR.